Theragene Pharmaceuticals Stock
Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.
Sign up today and learn more about Theragene Pharmaceuticals Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Theragene Pharmaceuticals Stock
Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases. As a biopharmaceutical company operating in both the US and Asia, we deliver unique product development models, utilizing the strengths of each region, while delivering safe, effective treatments. Our mission is to provide cutting-edge science, through resourceful product models, that significantly advance each product from the preclinical stage to finished product. From advancements in oncology to novel drug formulations, we are developing tomorrow's medicine.
Funding History
| March 2014 | $348K |
|---|---|
| August 2015 | $200K |
| December 2017 | $0 |
| December 2017 | $0 |
Management
SVP
Krisztina Zsebo
Press
eigerbio - Jun, 30 2017
Eiger BioPharmaceuticals Announces Sale of Non-Strategic Assets to Theragene PharmaceuticalsEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
